Hempalta Corp. (CVE:HEMP – Get Free Report) Director Darren Hartley Bondar purchased 310,474 shares of the stock in a transaction that occurred on Tuesday, December 24th. The stock was purchased at an average price of C$0.05 per share, with a total value of C$14,499.14.
Darren Hartley Bondar also recently made the following trade(s):
- On Tuesday, November 5th, Darren Hartley Bondar bought 200,000 shares of Hempalta stock. The shares were purchased at an average cost of C$0.04 per share, with a total value of C$8,000.00.
- On Monday, October 14th, Darren Hartley Bondar purchased 135,000 shares of Hempalta stock. The shares were purchased at an average cost of C$0.04 per share, for a total transaction of C$5,400.00.
Hempalta Price Performance
Shares of HEMP stock remained flat at C$0.04 on Tuesday. The company had a trading volume of 536,080 shares, compared to its average volume of 121,431. Hempalta Corp. has a 12-month low of C$0.04 and a 12-month high of C$0.30. The business has a 50 day moving average price of C$0.04 and a 200 day moving average price of C$0.11. The company has a market capitalization of C$3.80 million, a P/E ratio of -0.32 and a beta of -0.10. The company has a debt-to-equity ratio of 28.72, a quick ratio of 0.88 and a current ratio of 3.99.
About Hempalta
Hempalta Corp., an agricultural cleantech company, produces and processes industrial hemp in North America. It manufactures products using a process known as HempTrain that enables to produce a range of hemp-based commercial and consumer products. The company also engages in the hemp carbon credit market.
Recommended Stories
- Five stocks we like better than Hempalta
- What Are Some of the Best Large-Cap Stocks to Buy?
- 5 Reasons DraftKings Stock Looks Promising in the New Year
- How to Calculate Inflation Rate
- Cybersecurity Stocks: 1 Immediate Buy and 1 Dip Opportunity
- How to Use Stock Screeners to Find Stocks
- The Next 2 AI Winners Have Triple-Digit Upside Potential
Receive News & Ratings for Hempalta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hempalta and related companies with MarketBeat.com's FREE daily email newsletter.